TipRanks
IDEAYA Biosciences (DE:30J)
FRANKFURT:30J
Germany Market
30J
IDEAYA Biosciences
RESEARCH TOOLSreports

IDEAYA Biosciences (30J) Income Statement

5 Followers

IDEAYA Biosciences Income Statement

Last quarter (Q2 2026), IDEAYA Biosciences's total revenue was $8.86M, an increase of Infinity% from the same quarter last year. In Q2, IDEAYA Biosciences's net income was $-112.45M. See IDEAYA Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 218.71M$ 7.00M$ 23.39M$ 50.93M$ 27.94M
Gross Profit
$ -95.99M$ 3.17M$ 19.38M$ 48.83M$ 26.22M
Operating Expenses
$ 63.32M$ 330.14M$ 153.81M$ 111.33M$ 76.48M
Depreciation and Amortization
$ 4.59M$ 3.83M$ 4.01M$ 2.10M$ 1.73M
EBITDA
$ -154.72M$ -270.64M$ -108.95M$ -56.55M$ -48.04M
Operating Income
$ -159.31M$ -326.98M$ -134.43M$ -62.50M$ -50.27M
Other Income/Expenses
$ 45.62M$ 52.50M$ 21.47M$ 3.85M$ 506.00K
Pretax Income
$ -113.70M$ -274.48M$ -112.96M$ -58.66M$ -49.76M
Net Income
$ -113.70M$ -274.48M$ -112.96M$ -58.66M$ -49.76M
Per Share Metrics
Basic EPS
$ -1.28$ -3.36$ -1.96$ -1.42$ -1.41
Diluted EPS
$ -1.28$ -3.36$ -1.96$ -1.42$ -1.41
Weighted Average Shares Outstanding
 88.49M 81.68M 57.52M 41.44M 35.25M
Weighted Average Shares Outstanding (Diluted)
 88.49M 81.68M 57.52M 41.44M 35.25M
Currency in USD

IDEAYA Biosciences Earnings and Revenue History